Qulipta (atogepant)

pCPA File Number: 22394
Negotiation Status:
Concluded with an LOI
Indication(s):
Episodic migraine in adults (prevention)
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
SR0724-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: